Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1978 ARTÍCULOS , VIENDO DEL 1246 AL 1260

Anticholinergics and clinical outcomes amongst people with pre-existing dementia: A systematic review

Wang K, Alan J, Page AT, Dimopoulos E, Etherton-Beer C.

Maturitas. 2021 Sep;151:1-14. doi: 10.1016/j.maturitas.2021.06.004. Epub 2021 Jun 20.

The Neuroprotective Effects of Moderate and Regular Caffeine Consumption in Alzheimer's Disease

Zhou X, Zhang L.

Oxid Med Cell Longev. 2021 Aug 17;2021:5568011. doi: 10.1155/2021/5568011. eCollection 2021.

Diagnostic Validity of the Smart Aging Serious Game: An Innovative Tool for Digital Phenotyping of Mild Neurocognitive Disorder

Isernia S, Cabinio M, Di Tella S, Pazzi S, Vannetti F, Gerli F, Mosca IE, Lombardi G, Macchi C, Sorbi S, Baglio F.

J Alzheimers Dis. 2021;83(4):1789-1801. doi: 10.3233/JAD-210347.

Relationship between Central Obesity and the incidence of Cognitive Impairment and Dementia from Cohort Studies Involving 5,060,687 Participants

Tang X, Zhao W, Lu M, Zhang X, Zhang P, Xin Z, Sun R, Tian W, Cardoso MA, Yang J, Simó R, Zhou JB, Stehouwer CDA.

Neurosci Biobehav Rev. 2021 Nov;130:301-313. doi: 10.1016/j.neubiorev.2021.08.028. Epub 2021 Aug 28.

Detection of dementia on voice recordings using deep learning: a Framingham Heart Study

Xue C, Karjadi C, Paschalidis IC, Au R, Kolachalama VB.

Alzheimers Res Ther. 2021 Aug 31;13(1):146. doi: 10.1186/s13195-021-00888-3.

Clinical Characterization of Atypical Primary Progressive Aphasia in a 3-Year Longitudinal Study: A Case Report

Basilico S, Ciricugno A, Gelosa G, Magnani FG, Mosca L, Popescu C, Garibotto V, Sberna M, Paulesu E, Bottini G.

Cogn Behav Neurol. 2021 Sep 2;34(3):233-244. doi: 10.1097/WNN.0000000000000273.

Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer's dementia

Xiong LY, Ouk M, Wu CY, Rabin JS, Lanctôt KL, Herrmann N, Black SE, Edwards JD, Swardfager W.

Alzheimers Res Ther. 2021 Sep 3;13(1):147. doi: 10.1186/s13195-021-00892-7.

Personalized Repetitive Transcranial Magnetic Stimulation for Primary Progressive Aphasia

Pytel V, Cabrera-Martín MN, Delgado-Álvarez A, Ayala JL, Balugo P, Delgado-Alonso C, Yus M, Carreras MT, Carreras JL, Matías-Guiu J, Matías-Guiu JA.

J Alzheimers Dis. 2021;84(1):151-167. doi: 10.3233/JAD-210566.

The use of positron emission tomography/magnetic resonance imaging in dementia: A literature review

Lorking N, Murray AD, O'Brien JT.

Int J Geriatr Psychiatry. 2021 Oct;36(10):1501-1513. doi: 10.1002/gps.5586. Epub 2021 Jun 12.

A meta-analysis of randomised controlled trials of physical activity in people with Alzheimer's disease and mild cognitive impairment with a comparison to donepezil

Pisani S, Mueller C, Huntley J, Aarsland D, Kempton MJ.

Int J Geriatr Psychiatry. 2021 Oct;36(10):1471-1487. doi: 10.1002/gps.5581. Epub 2021 May 25.

Comparing Warfarin and 4 Direct Oral Anticoagulants for the Risk of Dementia in Patients With Atrial Fibrillation

Lee SR, Choi EK, Park SH, Jung JH, Han KD, Oh S, Lip GYH.

Stroke. 2021 Nov;52(11):3459-3468. doi: 10.1161/STROKEAHA.120.033338. Epub 2021 Sep 9.

Designing Dementia Care Pathways to Transform Non Dementia-Friendly Hospitals: Scoping Review

Riquelme-Galindo J, Lillo-Crespo M.

Int J Environ Res Public Health. 2021 Sep 3;18(17):9296. doi: 10.3390/ijerph18179296.

Analysis the Link between Periodontal Diseases and Alzheimer's Disease: A Systematic Review

Borsa L, Dubois M, Sacco G, Lupi L.

Int J Environ Res Public Health. 2021 Sep 3;18(17):9312. doi: 10.3390/ijerph18179312.

Accelerated functional brain aging in pre-clinical familial Alzheimer's disease

Gonneaud J, Baria AT, Pichet Binette A, Gordon BA, Chhatwal JP, Cruchaga C, Jucker M, Levin J, Salloway S, Farlow M, Gauthier S, Benzinger TLS, Morris JC, Bateman RJ, Breitner JCS, Poirier J, Vachon-Presseau E, Villeneuve S; Alzheimer’s Disease Neuroimaging Initiative (ADNI); Dominantly Inherited Alzheimer Network (DIAN) Study Group; Pre-symptomatic Evaluation of Experimental or Novel Treatments for Alzheimer’s Disease (PREVENT-AD) Research Group.

Nat Commun. 2021 Sep 9;12(1):5346. doi: 10.1038/s41467-021-25492-9.

EGb in the Treatment for Patients with VCI: A Systematic Review and Meta-Analysis

Zhan M, Sun L, Liu J, Zeng Z, Shen W, Li H, Wang Y, Han F, Shi J, Zeng X, Lu X, Zhang Y, Liao X.

Oxid Med Cell Longev. 2021 Aug 27;2021:8787684. doi: 10.1155/2021/8787684. eCollection 2021.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias